Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05797896 · ClinicalTrials.gov registry record
Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study
A clinical trial of Eye Diseases and Geographic Atrophy, sponsored by Complement Therapeutics.
- Active
- Registry status
- 250
- Enrollment target
- 20
- Study locations
NCT05797896 is a study of Eye Diseases and Geographic Atrophy that is active but no longer recruiting, run by Complement Therapeutics. The registered enrollment target is 250 participants, below the 741,294-participant average among 27 other Eye Diseases trials with a reported enrollment target (100% lower). The trial reports 20 study locations across 8 states.
The verdict
NCT05797896, a study of Eye Diseases and Geographic Atrophy, is active but no longer recruiting, sponsored by Complement Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 20
- Study locations
Study Summary
An observational study to investigate the natural history and evaluate biomarkers of participants with geographic atrophy secondary to age-related macular degeneration
Conditions Studied
Study Locations (20)
Other
- Belfast City Hospital - Belfast
- Bradford Royal Infirmary - Bradford
- Frimley Park Hospital - Frimley
- Gloucestershire Royal Hospital - Gloucester
- Liverpool Hospital - Liverpool
- Moorfields Eye Hospital - London
- Western Eye Hospital - London
- Manchester Royal Eye Hospital - Manchester
- Newcastle Hospital - Newcastle
- Nottingham City Hospital - Nottingham
Texas
- Retina Research Institute of Texas - Abilene
- Texas Retina Associates - Plano
- San Antonio Eye Center - San Antonio
California
- Global Research Management - Glendale
- Northern California Retina Vitreous Associates - Mountain View
Indiana
- Midwest Eye Institute - Carmel
Maryland
- Mid Atlantic Retina Specialists - Hagerstown
Nevada
- Sierra Eye Associates - Reno
Oregon
- Verum Research LLC - Eugene
Pennsylvania
- Mid Atlantic Retina - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-02-07 |
| Est. Completion | 2027-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05797896
The ClinicalTrials.gov registry entry for NCT05797896 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 741,294-participant average among 27 other Eye Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Complement Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Eye Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT05797896 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Other, Texas, California.
Frequently Asked Questions
What is clinical trial NCT05797896 about?
NCT05797896 is a clinical study titled "Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study". An observational study to investigate the natural history and evaluate biomarkers of participants with geographic atrophy secondary to age-related macular degeneration
What is the current status of trial NCT05797896?
This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2023-02-07. Estimated completion is 2027-07-31.
What conditions does trial NCT05797896 study?
This clinical trial studies the following conditions: Eye Diseases, Geographic Atrophy, Macular Degeneration, Retinal Disease, Retinal Degeneration.
Who is sponsoring clinical trial NCT05797896?
This trial is sponsored by Complement Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05797896 being conducted?
This trial has 20 study locations across California, Indiana, Maryland, Nevada, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eye Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adaptive Optics Retinal Imaging
RECRUITING
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging
RECRUITING
-
SGLT2 Inhibitors in Geographic Atrophy
RECRUITING · Phase 2
-
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
RECRUITING · NA
-
IRIS Registry: Intelligent Research in Sight Registry
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.